4 Results for "

QZ2135

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "QZ2135" in MCE Product Catalog:

Cat. No.: HY-170852
Target:  

PROTACs RET

Research Areas:  

Cancer

QZ2135 (compound 20) is a RET-targeted PROTAC degrader with in vivo antitumor properties in a Ba/F3-KIF5B-RET-G810C xenograft mouse model. The degradation activities of QZ2135 targeting KIF5B-RET have DC50 values of 4.7 nM (WT), 17.2 nM (V804M), and 73.8 nM (G810C), respectively. QZ2135 is composed of a target protein ligand (red part) RET ligand-3 (HY-170853), an E3 ligase ligand (blue part) Lenalidomide-F (HY-W039233), and a PROTAC Linker (black part) 7-Iodohept-1-yne (HY-W587352), in which the target protein ligand + linker form a conjugate RET Ligand-Linker Conjugate-1 (HY-170854) .
loading...
    loading...
Cat. No.: HY-170853
Research Areas:  

Others

RET ligand-3 is the ligand for targeting RET PROTAC QZ2135 (HY-170852) .
loading...
    loading...
Cat. No.: HY-W587352
CAS No.: 87462-66-6
Target:  

PROTAC Linkers

Research Areas:  

Others

7-Iodohept-1-yne is a PROTAC Linker that can be used to synthesize PROTAC QZ2135 (HY-170852) .
loading...
    loading...
Cat. No.: HY-170854
Research Areas:  

Cancer

RET Ligand-Linker Conjugate-1 is the conjugate composed of a RET ligand and a linker. RET Ligand-Linker Conjugate-1 can be used for synthesis of QZ2135 (HY-170852) .
loading...
    loading...